Recommend to a friend

Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib

Listen to experts report on current publications, posters, and sessions from a recent rheumatology conference. Faculty discuss the latest on Systemic sclerosis ILD and Progressive fibrosing ILD and discuss the implication of this information on current clinical practices for clinicians.

Friend's Name :
Friend's email :
You may provide a message here that will be included in the emailed recommendation. (2000 Character Max) Characters written:
Your comment